By NewsDesk  @infectiousdiseasenews Johnson & Johnson’s two-dose Ebola vaccine regimen is safe, well tolerated and produces a strong immune response in people over the age of one, according to...

By NewsDesk  @infectiousdiseasenews Jamaica’s Director of Family Health Services, in the Ministry of Health & Wellness, Dr. Melody Ennis announced Thursday that there have been no deaths due...

By NewsDesk  @infectiousdiseasenews The  Finnish Institute for Health and Welfare (THL) will consider the inclusion of the Johnson & Johnson coronavirus vaccine in the Finnish vaccine programme...

By NewsDesk  @infectiousdiseasenews The U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Johnson...

As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen ) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare...

Johnson & Johnson today announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020. They expect to initiate human clinical studies  at...

Here is a look at some interesting infectious disease and health news, opinion and research reported across the globe: WHO supports five countries to fight Lassa fever outbreaks With five countries...

The U.S. Agency for International Development (USAID) announced new partnerships to help countries eliminate and control neglected tropical diseases (NTDs). Over the next five years new and expanded partnerships...

By

Johnson & Johnson (NYSE: JNJ) is pleased to announce the formation of consortia with leading global research institutions and non-government organizations to work in conjunction with Janssen Pharmaceutical...

By

Johnson & Johnson today announced that it has made a commitment of up to $200 million to accelerate and significantly expand the production of an Ebola vaccine program in development at its Janssen...